DIN 02456621 — SYNJARDY 12.5 MG; 1000 MG
SYNJARDY is a tablet of Empagliflozin / Metformin marketed by BOEHRINGER INGELHEIM (CANADA) LTD LTEE. The full Empagliflozin / Metformin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02456621
- Brand name
- SYNJARDY
- Active ingredient
- Empagliflozin / Metformin
- Strength
- 12.5 MG; 1000 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- BOEHRINGER INGELHEIM (CANADA) LTD LTEE
- Health Canada status
- MARKETED
- Drug class
- SGLT2 inhibitor / biguanide combination (antihyperglycemic)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Empagliflozin / Metformin products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02456591 | SYNJARDY | 1000 MG; 5 MG | TABLET | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | MARKETED |
| 02456605 | SYNJARDY | 12.5 MG; 500 MG | TABLET | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | MARKETED |
| 02456583 | SYNJARDY | 5 MG; 850 MG | TABLET | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | MARKETED |
| 02456575 | SYNJARDY | 500 MG; 5 MG | TABLET | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | MARKETED |
| 02456613 | SYNJARDY | 850 MG; 12.5 MG | TABLET | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | MARKETED |